AI in Multimodality Imaging

Host

Durval Costa, MD, PhD, Radiopharmacology Lab

Venue

Seminar Room

Bio

Dimitris Visvikis is a director of research with the National Institute of Health and Medical Research (INSERM) and Director of the Medical Image Processing Lab in Brest. He obtained his PhD from the University of London in 1996 working in PET detector development within the Joint Department of Physics in the Royal Marsden Hospital and the Institute of Cancer Research. After working as a Senior Research Fellow in the Wolfson Brain Imaging Centre of the University of Cambridge he joined the Institute of Nuclear Medicine as Principal Medical Physicist in University College London where he introduced and worked for five years with one of the first clinical PET/CT systems in the world.

He has spent the majority of his scientific activity in the field of PET imaging, including developments in both hardware and software domains. His current research interests focus on improvement in PET/CT image quantitation for specific oncology applications, such as response to therapy and radiotherapy treatment planning, through the development of methodologies for detection and correction of respiratory motion, 4D PET image reconstruction, tumor radiomics multiparametric and multimodality modeling, as well as the development of computer assisted interventional radiotherapy and Monte Carlo based radiotherapy treatment dosimetry applications. In the last few years he has been developing AI methodologies based on deep learning for image reconstruction and analysis in multimodality imaging.

He is a member of numerous professional societies such as EFOMP (Projects committee Chair, AI Special Interest Group Chair), IPEM (Fellow, Past Vice-President International), IEEE (Fellow class of 2022, Past NPSS NMISC chair, ADCOM member), AAPM, SNM (CaIC board of directors 2007-2012), EANM (Chair Physics committee, 2020-2025). He is the first Editor in Chief of the IEEE Transactions in Radiation and Plasma Medical Sciences (2017-). He is currently the president of the INSERM national scientific commission for Healthcare Technologies (2022-2026). He has received different awards including the 2019 Richard F. Shea Distinguished NPSS Member Award, the 2020 Edward J Hoffman Award of the Society of Nuclear Medicine and Molecular Imaging, “for contributions to advances in PET imaging and to education and dissemination of findings within the scientific community”, and the 2020 IEEE Nuclear and Plasma Sciences Society and Nuclear Medical Imaging Steering Committee, Medical Imaging Technical Achievement Award, “for contributions to PET/CT imaging methodological developments dedicated to respiratory motion correction, image reconstruction, detector modeling and automated image analysis and processing for predictive modeling in oncology”. 

Register here.

About CR Colloquia Series

Champalimaud Research (CR) Colloquia Series is a seminar programme organised by the Champalimaud Centre for the Unknown to promote the discussion about the most interesting and significant questions in neuroscience and physiology & cancer with appointed speakers by the CR Community.